Physician profile
William Waldrop
NPI 1861587040
$1,231.18
in general payments reported to CMS, 2019-2025
18 companies · $79.87 in 2025
The $79.87 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $202 · 2020: $58.02 · 2021: $28.91 · 2022: $214 · 2023: $448 · 2024: $201 · 2025: $79.87.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $728.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $728.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $198.72 | 2021-2024 | Vraylar |
| Janssen Pharmaceuticals, INC | $134.13 | 2019-2025 | Spravato |
| Takeda Pharmaceuticals U.S.A., INC. | $132.14 | 2019-2024 | Trintellix |
| Otsuka America Pharmaceutical, INC. | $123.42 | 2022-2024 | Rexulti, Abilify Maintena |
| Teva Pharmaceuticals USA, INC. | $105.75 | 2019-2025 | Austedo Xr, Austedo Xr |
| Neurocrine Biosciences, INC. | $92.60 | 2019-2025 | Ingrezza |
| Vanda Pharmaceuticals INC. | $92.53 | 2023 | Hetlioz, Fanapt |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $87.37 | 2022-2025 | Caplyta |
| Allergan, INC. | $59.52 | 2019-2020 | |
| Alkermes, INC. | $58.45 | 2023-2024 | Aristada, Lybalvi |
| Axsome Therapeutics, INC. | $26.45 | 2024 | Auvelity |
| Corium, LLC | $22.95 | 2023 | Azstarys |
| Ironshore Pharmaceuticals INC. | $18.80 | 2019 | |
| Almatica Pharma LLC | $16.89 | 2021 | |
| Idorsia Pharmaceuticals US INC | $16.87 | 2023 | Quviviq |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $15.92 | 2019 | |
| Lundbeck LLC | $15.88 | 2023 | Rexulti |
| Bausch Health US, LLC | $12.79 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Waldrop listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.